Hopp til innhold

Prosjekt

Kikhoste epidemiologien med fokus på effekten av boostervaksinene i den Norske barnevaksinasjonsprogrammet på den alders-spesifikke kikhoste insidensen - prosjektbeskrivelse

Publisert Oppdatert

The aim of this study is to investigate the epidemiology of pertussis in Norway during years 1996–2019, with special attention to the changes occurring after the introduction of the 15-year booster.


Sammendrag

Pertussis (whooping cough) is an important public health concern in Norway despite very high vaccination coverage of the childhood vaccination program. Due to an increased incidence of whooping cough among teenagers after introducing a booster for 7-year olds in 2006, a booster given at 15-year old was introduced in 2013-2014. The aim of this study is to investigate the epidemiology of pertussis in Norway during years 1996–2019, with special attention to the changes occurring after the introduction of the 15-year booster. This will be done by linking data from two registries, the Norwegian Surveillance System for Communicable Diseases (MSIS) and the Norwegian Immunization Registry (SYSVAK). MSIS contains all cases of pertussis notified in Norway, and SYSVAK contains nationwide, individualized data on vaccine history. The results are needed both to sustain high quality of the childhood vaccination programme as well as to guide potential changes in vaccination policy.

Se fullstendig prosjektbeskrivelse på Cristin for mer informasjon om resultater, deltakere, kontakter med mer

Prosjektdeltakere

Prosjektleder

Anneke Steens, Folkehelseinstituttet

Prosjektdeltakere

Didrik Frimann Vestrheim, Folkehelseinstituttet
Elina Seppälä, Folkehelseinstituttet
Margrethe Greve-Isdahl, Folkehelseinstituttet
Håkon Bøås, Universitetet i Oslo
Birgitte Freisleben de Blasio, Folkehelseinstituttet

Om prosjektet